Effect of ınhaler Use on Oral Health in COPD Patients

NCT ID: NCT07000604

Last Updated: 2025-06-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-30

Study Completion Date

2025-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study was to evaluate the effect of oral health education given to individuals diagnosed with COPD and using inhaled medication.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Before the research data are collected, the purpose, content, scope and duration of the research will be explained in one-to-one interviews with the participants. Verbal and written informed consent will be obtained from the participants. After the participants gave consent to the study, they will be divided into intervention and control groups by simple random sampling method. Participants will be asked to answer the questions in the data collection tools as they see fit and to answer all of the questions. The data collection form will be applied through face-to-face interviews with participants who meet the inclusion criteria. After each completed questionnaire, the researchers will check whether the answers to the survey questions are missing. When unanswered questions are identified, participants will be invited to fill in the missing information. The completion of the questionnaires and training is planned to take an average of 20-25 minutes for each participant. The experimental group will receive training intervention. No education will be given to the control group. After 3 months, an appointment will be made to evaluate oral health

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Obstructive Pulmonary Disease (COPD)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

EXPERIMENTAL AND CONTROL GROUP
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

DENEY GRUBU

Oral care training will be given to 40 randomly selected patients and their oral health will then be evaluated.

Group Type OTHER

Mouth Care Training

Intervention Type OTHER

Patients will be educated on how to care for their mouths after using inhaled medication.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mouth Care Training

Patients will be educated on how to care for their mouths after using inhaled medication.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with COPD for at least 6 months,
* Outpatient and inpatient,
* Consent to participate in the research,
* Not under the age of eighteen,
* With a metered dose inhaler (MDI) in treatment,
* No communication barriers,
* No COPD exacerbation and/or respiratory tract infection,
* According to the GOLD report; mild (Stage 1), moderate (Stage 2), severe (Stage 3).

Exclusion Criteria

* Diagnosed with COPD for less than 6 months,
* Refused to participate in the research,
* Treatment without metered dose inhalers (MDIs),
* Uncommunicative,
* Those who withdrew from participating in the study during data collection,
* Not completing the survey,
* COPD exacerbation and/or respiratory tract infection,
Minimum Eligible Age

35 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Çankırı Karatekin University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Betül YALÇIN

NURSE

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Betül Yalçın, 2

Role: PRINCIPAL_INVESTIGATOR

Çankırı Karatekin University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Çankiri Devlet Hastanesi

Çankırı, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

BETÜL YALÇIN, 2

Role: CONTACT

+905536048980

özlem bulantekin düzalan, 1

Role: CONTACT

+905063801930

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

03-07-2024-15-COPD01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.